In the obese trial cohort, 1 mg moved 24-hour heart rate by +0.7 bpm in the first week, essentially placebo. In a healthy lean Phase 1b group, the same dose raised heart rate by about 10 bpm, with a peak near 15 to 20 bpm around days 4 to 6. Lean, younger participants had more reactive heart-rate control than the sedentary, obese, and metabolically stressed trial population
Guided by ASA-2023 and SPAQI consensus, but calibrated for high-BMI populations, our protocol uses the decision nodes laid out in Table 1
But over time, subtle symptoms can pile up
Data were analysed from 1 December 2017 until 30 November 2023
But patients should understand something important: Just because a peptide is available online or offered by a clinic does not automatically mean it has formal FDA approval or clear regulatory authorization
These pens carry manufacturer-determined expiration dates based on real-time and accelerated stability data